Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Deaths of psychiatric patients during heat waves.
Bark N. Bark N. Psychiatr Serv. 1998 Aug;49(8):1088-90. doi: 10.1176/ps.49.8.1088. Psychiatr Serv. 1998. PMID: 9712220
The impact of cognitive remediation on psychiatric symptoms of schizophrenia.
Bark N, Revheim N, Huq F, Khalderov V, Ganz ZW, Medalia A. Bark N, et al. Schizophr Res. 2003 Oct 1;63(3):229-35. doi: 10.1016/s0920-9964(02)00374-2. Schizophr Res. 2003. PMID: 12957702 Clinical Trial.
Evaluation of the routine clinical use of the Brief Psychiatric Rating Scale (BPRS) and the Abnormal Involuntary Movement Scale (AIMS).
Bark N, Florida D, Gera N, Varardi R, Harghel L, Adlington K. Bark N, et al. J Psychiatr Pract. 2011 Jul;17(4):300-3. doi: 10.1097/01.pra.0000400269.68160.e6. J Psychiatr Pract. 2011. PMID: 21775833
Cognitive deficits and psychopathology in elderly schizophrenic patients.
Lindenmayer JP, Negrón AE, Shah S, Lowinger R, Kennedy G, Bark N, Hyman R. Lindenmayer JP, et al. Among authors: bark n. Am J Geriatr Psychiatry. 1997 Winter;5(1):31-42. Am J Geriatr Psychiatry. 1997. PMID: 9169243
Heatstroke in psychiatric patients: two cases and a review.
Bark NM. Bark NM. J Clin Psychiatry. 1982 Sep;43(9):377-80. J Clin Psychiatry. 1982. PMID: 6126476
Adjunctive high-dose glycine in the treatment of schizophrenia.
Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR. Javitt DC, et al. Among authors: bark n. Int J Neuropsychopharmacol. 2001 Dec;4(4):385-91. doi: 10.1017/S1461145701002590. Int J Neuropsychopharmacol. 2001. PMID: 11806864 Clinical Trial.
Glycine is an agonist at brain N-methyl-D-aspartate receptors and crosses the blood-brain barrier following high-dose oral administration. ...
Glycine is an agonist at brain N-methyl-D-aspartate receptors and crosses the blood-brain barrier following high-dose oral administra …
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB. Krakowski MI, et al. Among authors: bark n. Arch Gen Psychiatry. 2006 Jun;63(6):622-9. doi: 10.1001/archpsyc.63.6.622. Arch Gen Psychiatry. 2006. PMID: 16754835 Clinical Trial.
Physically assaultive subjects with schizophrenia or schizoaffective disorder who were inpatients in state psychiatric facilities were randomly assigned to treatment with clozapine (n = 37), olanzapine (n = 37), or haloperidol (n = 36). ...
Physically assaultive subjects with schizophrenia or schizoaffective disorder who were inpatients in state psychiatric facilities were rando …
Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
Smith RC, Jin H, Li C, Bark N, Shekhar A, Dwivedi S, Mortiere C, Lohr J, Hu Q, Davis JM. Smith RC, et al. Among authors: bark n. Schizophr Res. 2013 Jan;143(1):18-24. doi: 10.1016/j.schres.2012.10.023. Epub 2012 Nov 29. Schizophr Res. 2013. PMID: 23200554 Clinical Trial.
Psychopathology of Schizophrenia: initial validation of a 5-factor model.
Lindenmayer JP, Bernstein-Hyman R, Grochowski S, Bark N. Lindenmayer JP, et al. Among authors: bark n. Psychopathology. 1995;28(1):22-31. doi: 10.1159/000284896. Psychopathology. 1995. PMID: 7871117
High-dose treatment with haloperidol: the effect of dose reduction.
Volavka J, Cooper TB, Czobor P, Lindenmayer JP, Citrome LL, Mohr P, Bark N. Volavka J, et al. Among authors: bark n. J Clin Psychopharmacol. 2000 Apr;20(2):252-6. doi: 10.1097/00004714-200004000-00020. J Clin Psychopharmacol. 2000. PMID: 10770466 Clinical Trial.
Patients who were receiving high doses of haloperidol were screened, and those patients whose plasma levels were at least 15 ng/mL were randomly assigned to an experimental group (N = 11) or to a control group (N = 12). ...
Patients who were receiving high doses of haloperidol were screened, and those patients whose plasma levels were at least 15 ng/mL were rand …
47 results
Jump to page
Feedback